Kary Eldred

CIK: 0001543425

Transaction Breakdown

Open Market Buys (P)5 (71.4%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GALT

GALECTIN THERAPEUTICS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

GALT
GALECTIN THERAPEUTICS INC
Feb 6, 2026
Purchase(P)
Direct
300 shares at avg. $2.70$810
GALT
GALECTIN THERAPEUTICS INC
Jan 16, 2026
Award(A)
Stock option (right to buy)
Direct
60K shares-
GALT
GALECTIN THERAPEUTICS INC
Dec 23, 2025
Purchase(P)
Direct
700 shares at avg. $3.73$3K
GALT
GALECTIN THERAPEUTICS INC
Jul 21, 2025
Purchase(P)
Direct
1K shares at avg. $2.92$3K
GALT
GALECTIN THERAPEUTICS INC
Jan 23, 2025
Award(A)
Stock Option (right to buy)
Direct
60K shares-
GALT
GALECTIN THERAPEUTICS INC
Dec 24, 2024
Purchase(P)
Direct
13.5K shares at avg. $0.82$11K
GALT
GALECTIN THERAPEUTICS INC
Oct 23, 2024
Purchase(P)
Direct
500 shares at avg. $2.60$1K

		Type	Shares	Price		Ownership
Feb 6, 2026	GALT GALECTIN THERAPEUTICS INC	Purchase(P)	300	$2.70	$810	Direct
Jan 16, 2026	GALT GALECTIN THERAPEUTICS INC	Award(A) Stock option (right to buy)	60,000	-	-	Direct
Dec 23, 2025	GALT GALECTIN THERAPEUTICS INC	Purchase(P)	700	$3.73	$2,611	Direct
Jul 21, 2025	GALT GALECTIN THERAPEUTICS INC	Purchase(P)	1,000	$2.92	$2,925	Direct
Jan 23, 2025	GALT GALECTIN THERAPEUTICS INC	Award(A) Stock Option (right to buy)	60,000	-	-	Direct
Dec 24, 2024	GALT GALECTIN THERAPEUTICS INC	Purchase(P)	13,469	$0.82	$11,045	Direct
Oct 23, 2024	GALT GALECTIN THERAPEUTICS INC	Purchase(P)	500	$2.60	$1,300	Direct

1-7 of 7 transactions

About ELDRED KARY

ELDRED KARY (SEC CIK 0001543425) files insider reports with the SEC as Director of GALECTIN THERAPEUTICS INC (GALT).

Signal8 holds 8 ownership filings by ELDRED KARY, all Form 4s, filed between Oct 23, 2024 and Feb 9, 2026. Those filings report 7 transactions, from Oct 23, 2024 to Feb 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ELDRED KARY's filings is in NORCROSS, GA.

Recent filings by ELDRED KARY

Feb 6, 2026: Open-market purchase of GALT shares (Form 4, code P).
Jan 16, 2026: Grant or award of GALT derivative securities (Form 4, code A).
Dec 23, 2025: Open-market purchase of GALT shares (Form 4, code P).
Jul 21, 2025: Open-market purchase of GALT shares (Form 4, code P).
Jan 23, 2025: Grant or award of GALT derivative securities (Form 4, code A).

Other insiders filing for GALECTIN THERAPEUTICS INC (GALT)

Uihlein Richard E, Director
Jamil Khurram, Chief Medical Officer
Shlevin Harold H., Director
Brem Henry, Director
LEWIS JOEL, President and CEO
CARSON BENJAMIN SR, Director

How to read Form 4 transaction codes